Described herein are pharmaceutical packaging systems which reduce oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medications, these kinds of systems including a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with pretty very low permeabi